MedPath

Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS

Not Applicable
Completed
Conditions
Peritoneal Dialysis, Continuous Ambulatory
Interventions
Procedure: Fluid management based on the clinical information alone
Device: BCM-guided fluid management
Registration Number
NCT01887262
Lead Sponsor
Seoul National University Hospital
Brief Summary

Bioimpedance-guided fluid management in peritoneal dialysis patients may provide better protection of residual renal function over 1 year period, compared with management guided by clinical information alone - such as blood pressure, body weight, and physician's physical examination.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria
  • age bwten 20 and 75
  • peritoneal dialysis > 4 weeks duration
  • written consent
  • daily urine output > 500 ml
Read More
Exclusion Criteria
  • subjects who are contraindicated to the bioimpedance measurement (pacemaker insertion state, defibrillator state, amputee, prosthesis, metal implants)
  • pregnant women
  • subjects who are expected to discontinue peritoneal dialysis with one year
  • mixed dialysis modality (peritoneal + hemodialysis)
  • hypoalbuminemic subjects (serum albumin < 3.3 g/dL)
  • high blood pressure (> 160/100 mmHg despite antihypertensive medications)
  • severe heart failure (NYHA FC III, or IV)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlFluid management based on the clinical information aloneBCM will be measured at the beginning and end of the study, respectively. However, the BCM results will be blinded to the physicians and the control group. The physician will prescribe drugs, PD fluids, and dietary education to the patients based on the clinical information alone - such as blood pressure, edema and body weight.
InterventionBCM-guided fluid managementIncident peritoneal dialysis (PD) patients who are randomly allocated to BCM-guided fluid management will receive BCM measurement every two months over 1-year period. The BCM results will be notified to the physicians and the participating subjects. Based on the BCM results along with the clinical information such as blood pressure, edema and weight, the physicians will prescribe PD fluid and diuretics, targeting within 1L of overhydration status. They will prescribe dietary education to the patient, if necessary.
Primary Outcome Measures
NameTimeMethod
delta GFRbaseline and 12th month

change of glomerular filtration rate from baseline to the 12th month

Secondary Outcome Measures
NameTimeMethod
GFRat 12th month

glomerular filtration rate measured by urine collection, calculated by the mean of creatinine and urea clearance

echocardiographic parameters12 months period

parameters obtained by echocardiographic measurements such as left ventracular mass index (LVMi), E/e' ratio, left vetricular end-diastolic volume (LVEDP), left ventracular ejection fraction (LVEF), left atrial volume indx (LAVI)

time to anuriaover 12 months

time to the anuric state (urine volume \< 100cc/d)

BP12th month

systolic, diastolic blood pressure, pulse pressure

cardiovascular eventover 12 months

fatal and nonfatal cardiovascular events - acute myocardial infarction (AMI), stroke, unstable angina, amputation, cardiovascular revascularization

BCM parametersbaseline and 12th month

parameters measured by body composition monitoring (BCM), such as overhydration(OH), extracellular water (ECW), extracellular-to-intracellular water ratio (ECW/ICW)

Trial Locations

Locations (1)

Seoul National University Hospital Clinical Trial Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath